CIK 0001781983 · Non-accelerated filer<br>Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 52 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-12 | Gilad Oren President/CEO | Grant or award | +20,175 | 393,895 | ||
| 2026-03-12 | Gilad Oren President/CEO | Grant or award · Stock Options (Right to Buy) | +80,700 | 80,700 | ||
| 2026-03-12 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Grant or award | +10,095 | 43,528 | ||
| 2026-03-12 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Grant or award · Stock Options (Right to Buy) | +40,380 | 40,380 | ||
| 2026-01-30 | Gilad Oren President/CEO | Purchase | +28,100 | $0.89 | $25K | 373,720 |
| 2026-01-30 | Gilad Oren President/CEO | Purchase · Common Warrant | +28,100 | 28,100 | ||
| 2026-01-30 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase | +5,700 | $0.89 | $5K | 33,433 |
| 2026-01-30 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase · Common Warrant | +5,700 | 5,700 | ||
| 2025-12-10 | Duey Marc Director | Purchase | +21,459 | $1.17 | $25K | 256,155 |
| 2025-12-10 | Duey Marc Director | Purchase · Common Warrant | +21,459 | 21,459 | ||
| 2025-12-10 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase | +5,000 | $1.17 | $6K | 27,733 |
| 2025-12-10 | Hamill John P. SrVP/CFO/Prin Fin & Acct Ofcr | Purchase · Common Warrant | +5,000 | 5,000 | ||
| 2025-12-10 | Gilad Oren President/CEO | Purchase · Pre-Funded Warrant | +21,459 | $1.17 | $25K | 21,459 |
| 2025-12-10 | Gilad Oren President/CEO | Purchase · Common Warrants | +21,459 | 21,459 | ||
| 2025-06-05 | Seizinger Bernd R. Director | Grant or award | +1,045 | 45,775 | ||
| 2025-06-05 | Seizinger Bernd R. Director | Grant or award · Stock Options (Right to Buy) | +4,185 | 4,185 | ||
| 2025-06-05 | Peters Richard Director | Grant or award | +1,045 | 3,119 | ||
| 2025-06-05 | Peters Richard Director | Grant or award · Stock Options (Right to Buy) | +4,185 | 4,185 | ||
| 2025-06-05 | Pamukcu Rifat Director | Grant or award | +1,045 | 5,446 | ||
| 2025-06-05 | Pamukcu Rifat Director | Grant or award · Stock Options (Right to Buy) | +4,185 | 4,185 |
Page 2 of 10 · 197 trades